The Krembil Research Institute has partnered with The Globe and Mail to release a magazine series highlighting Krembil research advancements.
The third magazine in the series was distributed to Globe and Mail subscribers across Canada on September 7, 2017 and focuses on success stories in arthritis research. Read the full issue online here.
“At Krembil, we’ve diligently built one of the top research programs in the world dedicated to finding [the cure for arthritis],” says Dr. Nizar Mahomed, Medical Director of the Arthritis Program at UHN. “We employ a collaborative, innovative team-first approach that’s committed to stopping this disease in its tracks.”
The current issue features a wide range of stories on Krembil researchers and arthritis research projects. These include a story on how Dr. Armand Keating is leading the first North American mesenchymal stem cell trial to treat patients with knee osteoarthritis at the source—an approach that Dr. Nizar Mahomed believes may one day make knee joint replacements obsolete.
Also featured are philanthropists Tony Fell and Bryce Douglas, who are the founding co-chairs of the Campaign to Cure Arthritis. As longtime supporters of the Arthritis Program at Toronto Western Hospital, they understand the devastating impact that arthritis can have on people’s lives and the economy, and why private sector donations are critical to finding cures.
“There are many exciting stories of progress and success emerging from our laboratories,” explains Dr. Donald Weaver. “Some of these stories are told in this magazine. This is only a sampling of what we do and what we are capable of.”
Links to all three Globe and Mail magazines are available here.